![Clive Meanwell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Clive Meanwell
Gründer bei
POPULATION HEALTH INVESTMENT CO., INC.
Vermögen: 532 671 $ am 30.06.2026
Profil
Dr. Clive A. Meanwell ist Chief Executive Officer & Director bei Population Health Investment Co., Inc. und Chief Executive Officer bei Rempex Pharmaceuticals, Inc. sowie Director & Chief Innovation Officer bei The Medicines Co. und Executive Chairman bei Population Health Partners LLC. Er ist Mitglied des Verwaltungsrats von Population Health Investment Co., Inc., BB Biotech AG, Pharmaceutical Research & Manufacturers of America und The Medicines Co. Dr. Meanwell war zuvor als Chief Innovation Officer & Director bei The Medicines Co., als Managing Director & Partner bei MPM Capital Inc, als Senior Vice President bei Hoffmann-La Roche, Inc. und als President bei Targanta Therapeutics Corp. tätig. Außerdem war er Mitglied des Vorstands bei Endo Pharmaceuticals Holdings, Inc. Er erhielt seinen Doktortitel von der University of Birmingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BB BIOTECH AG 0.01% | 31.12.2025 | 5’163 ( 0.01% ) | 312 027 $ | 30.06.2026 |
FRACTYL HEALTH, INC. 0.18% | 10.06.2026 | 277’890 ( 0.18% ) | 220 645 $ | 30.06.2026 |
Aktive Positionen von Clive Meanwell
| Unternehmen | Position | Beginn |
|---|---|---|
| POPULATION HEALTH INVESTMENT CO., INC. | Gründer | 11.09.2020 |
| FRACTYL HEALTH, INC. | Direktor/Vorstandsmitglied | 16.06.2021 |
Annovation BioPharma, Inc.
 Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Vorstandsvorsitzender | - |
Hugo Health LLC
 Hugo Health LLC Information Technology ServicesTechnology Services Provides healthcare IT services | Direktor/Vorstandsmitglied | 01.01.2021 |
Comanche Biopharma Corp.
 Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical biopharmaceutical company which develops a novel siRNA therapy for the treatment of preeclampsia | Direktor/Vorstandsmitglied | 01.01.2021 |
Saama Technologies, Inc.
 Saama Technologies, Inc. Packaged SoftwareTechnology Services Offers AI-backed SaaS solutions | Direktor/Vorstandsmitglied | 19.11.2021 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Corporate Officer/Principal | - |
Population Health Partners LLC
 Population Health Partners LLC Investment ManagersFinance Population Health Partners invests in companies located in the United States. The firm focuses on life science and healthcare technology sector. It provides financing for early stage capital transactions. | Gründer | 01.05.2020 |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Clive Meanwell
| Unternehmen | Position | Ende |
|---|---|---|
| ░░ ░░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░░░░░░ | - |
Ausbildung von Clive Meanwell
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
69
Beziehungen ersten Grades
20
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 20 |
|---|---|
BB Biotech AG
 BB Biotech AG Financial ConglomeratesFinance Provides investment services for biotechnology sector | Finance |
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Endo Health Solutions, Inc.
 Endo Health Solutions, Inc. Pharmaceuticals: MajorHealth Technology Manufactures analgesics pharmaceutical products | Health Technology |
The Medicines Co.
 The Medicines Co. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that develops drugs for acute cardiovascular care | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology advocacy organization representing biotech companies, industry leaders and state biotech associations | Commercial Services |
Targanta Therapeutics Corp.
 Targanta Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel antibacterial pro drugs | Health Technology |
Annovation BioPharma, Inc.
Annovation BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products in the field of anesthesia, sedation and sleep | Health Technology |
MPM BioImpact LLC
 MPM BioImpact LLC Investment ManagersFinance MPM Capital invests in both public and private companies located in the United States. The firm targets companies operating in the fields of biotechnology, healthcare and life science sectors. It participates in early stage capital transactions. | Finance |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Operates as a biotech company that develops pharmaceutical and diagnostic solutions | Health Technology |
University of Birmingham
 University of Birmingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Saama Technologies, Inc.
Saama Technologies, Inc. Packaged SoftwareTechnology Services Offers AI-backed SaaS solutions | Technology Services |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Rempex Pharmaceuticals, Inc.
 Rempex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and discovers new antibacterial drugs | Health Technology |
Fractyl Health, Inc.
 Fractyl Health, Inc. BiotechnologyHealth Technology Develops and sells therapeutics for metabolic diseases, type 2 diabetes & obesity | Health Technology |
Hugo Health LLC
Hugo Health LLC Information Technology ServicesTechnology Services Provides healthcare IT services | Technology Services |
Invivyd, Inc.
 Invivyd, Inc. BiotechnologyHealth Technology Develops antibody-based solutions for infectious diseases | Health Technology |
Population Health Partners LLC
Population Health Partners LLC Investment ManagersFinance Population Health Partners invests in companies located in the United States. The firm focuses on life science and healthcare technology sector. It provides financing for early stage capital transactions. | Finance |
Population Health Investment Co., Inc.
 Population Health Investment Co., Inc. Financial ConglomeratesFinance Operates as a special purpose acquisition company | Finance |
EQRx, Inc.
 EQRx, Inc. Pharmaceuticals: MajorHealth Technology Develops and delivers medicines for lung cancer | Health Technology |
Comanche Biopharma Corp.
Comanche Biopharma Corp. Miscellaneous Commercial ServicesCommercial Services Operates as a preclinical biopharmaceutical company which develops a novel siRNA therapy for the treatment of preeclampsia | Commercial Services |
